Sensei Biotherapeutics (SNSE)
(Delayed Data from NSDQ)
$0.63 USD
-0.01 (-1.30%)
Updated Aug 9, 2024 03:58 PM ET
3-Hold of 5 3
D Value C Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -0.24 |
EPS Last Quarter | -0.28 |
Last EPS Surprise | -12.00% |
ABR | 1.00 |
Earnings ESP
|
-23.40% |
---|---|
Current Year | -1.04 |
Next Year | -1.12 |
EPS (TTM) | -1.18 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.24 | -0.25 | -1.04 | -1.12 |
# of Estimates | 2 | 2 | 3 | 2 |
Most Recent Consensus | -0.29 | -0.30 | -1.20 | -0.92 |
High Estimate | -0.18 | -0.20 | -0.79 | -0.92 |
Low Estimate | -0.29 | -0.30 | -1.20 | -1.32 |
Year ago EPS | -0.28 | -0.30 | -1.22 | -1.04 |
Year over Year Growth Est. | 14.29% | 16.67% | 14.75% | -7.38% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 1 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 1 |
Down Last 30 Days | 0 | 0 | 0 | 1 |
Down Last 60 Days | 0 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.24 | -0.25 | -1.04 | -1.12 |
7 Days Ago | -0.26 | -0.28 | -1.09 | -1.12 |
30 Days Ago | -0.26 | -0.28 | -1.09 | -1.12 |
60 Days Ago | -0.26 | -0.28 | -1.09 | -1.12 |
90 Days Ago | -0.24 | -0.26 | -1.00 | -0.91 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.29 | -0.30 | -1.20 | -0.92 |
Zacks Consensus Estimate | -0.24 | -0.25 | -1.04 | -1.12 |
Earnings ESP | -23.40% | -20.00% | -15.02% | 17.86% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.28 | -0.32 | -0.30 | -0.28 | NA |
Estimate | -0.25 | -0.29 | -0.32 | -0.28 | NA |
Difference | -0.03 | -0.03 | 0.02 | 0.00 | -0.01 |
Surprise | -12.00% | -10.34% | 6.25% | 0.00% | -4.02% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more